CompaniesAlucent Biomedical

Alucent Biomedical

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

142

By Phase

NA: 3PHASE1: 2

By Status

ACTIVE_NOT_RECRUITING: 2COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT04188262
NCT05454995
NCT05455021
NCT05462223
Hover over trial bars to see details

Recent Trials

NCT05462223Lead Sponsor
Alucent Vessel Restoration System for AVF
NARecruiting
30 participants
Started: Jul 15, 2022 · Completed: Dec 15, 2024
NCT05454995Lead Sponsor
Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II
NAActive, not recruiting
50 participants
Started: Nov 15, 2021 · Completed: Nov 15, 2027
NCT05455021Lead Sponsor
Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I
NAActive, not recruiting
50 participants
Started: Nov 15, 2021 · Completed: Nov 15, 2026
NCT04188262Lead Sponsor
Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)
PHASE1Completed
9 participants
Started: May 22, 2020 · Completed: May 31, 2022
NCT03148808Lead Sponsor
Natural Vascular Scaffold (NVS) Therapy
PHASE1Completed
3 participants
Started: May 25, 2017 · Completed: Oct 29, 2018
Funding History (3)
D
Apr 20, 2023
Filing
D
Oct 15, 2020
Filing
D
Jan 27, 2015
Filing